Sign for Notice Everyday    Sign Up| Sign In| Link|

Our Sponsors

  • ESTA - Electronic System for Travel Authorization
Receive Latest News

Share Us

WCBG- 2018 - The 2nd World Congress of Biosimilars and Generics-2018 (WCBG-2018)

View: 642

Website | Edit Freely

Category • Biosimilars & Biobetters; • Chemical Generics; • Biosimilar Development & Manufacturing; • Biosimilars & Generics Applications; • Green Bioprocessing and Biomanufacturing; • Business & Generic Pharmaceuticals; • Biosimilars and Generics Market; • Formulation and SDDS of Generics

Deadline: April 01, 2018 | Date: April 25, 2018-April 27, 2018

Venue/Country: Dalian, China

Updated: 2017-07-07 12:09:05 (GMT+9)

Call For Papers - CFP

The theme of the congress is "Let Everyone can Enjoy the Fruits of Drug Innovation ". It includes keynote forum, Parallel Forum, posters, networking dinner, presentations and exhibitions. WCBG-2018 will host leading scientists from the academia and industry worldwide, to discuss the latest developments in Biosimilars and Generics. 300 participants from 30 countries will gather in beautiful Dalian for the event. 50% of attendees will from the pharmaceutical industry with an additional 50% from academia. With Generics development in Asia growing so rapidly, the WCBG-2018 promises to be one of the most exciting opportunities for those who are seeking to broaden their professional network! Additionally, Dalian is a beautiful coastal city with a long history and abundant scenic spots of culture, you will enjoy yourself stay in this beautiful city. Please click the following link for more details of WCBG:

Keywords: Accepted papers list. Acceptance Rate. EI Compendex. Engineering Index. ISTP index. ISI index. Impact Factor.
Disclaimer: ourGlocal is an open academical resource system, which anyone can edit or update. Usually, journal information updated by us, journal managers or others. So the information is old or wrong now. Specially, impact factor is changing every year. Even it was correct when updated, it may have been changed now. So please go to Thomson Reuters to confirm latest value about Journal impact factor.